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Background: Chronic widespread pain (CWP) is common and associated with prominent negative consequences.
The aim of this study was to assess the prevalence of persistent CWP in an 11-year prospective cohort study in the
general population, and to examine anxiety, depression, alcohol use, poor sleep, body mass index (BMI) and chronic
disease, along with demographic, lifestyle and other health-related variables as possible predictors for the assumed
CWP persistence.
Methods: CWP was defined as having pain at three or more predefined sites (involving the trunk and upper and
lower limbs) for at least three months in the last year. We used a Norwegian general population cohort of 28,367
individuals who responded to both the second (1995–1997) and the third (2006–2008) waves of the Nord-Trøndelag
Health Study (HUNT2 and HUNT3, respectively). Data were analysed with logistic regression models.
Results: CWP prevalence in HUNT2 was 17%. Of those reporting CWP in HUNT2, 53% still reported CWP at follow-up in
HUNT3. Adjusted analyses revealed that depression and alcohol consumption were not substantially associated with
the 11-year prospective CWP outcome. Poor sleep, obesity and chronic disease predicted persistent CWP, and being
male and/or 60 years or older was protective.
Conclusions: This cohort study revealed that nearly half of the participants with baseline CWP resolved from CWP
11 years later. Among those whose CWP did not resolve, obesity, sleeping problems and chronic disease predicted
CWP persistence, while aging and male sex was protective. Anxiety, mixed anxiety and depression, former smoking,
and overweight were weakly associated, while depression, moderate exercise, and alcohol use were not associated
with persistent CWP.
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Chronic pain is common in the general population with
a prevalence ranging from 20% to 55% [1-5]. Chronic
pain persists beyond three months and is characterized
by repeated or continuous pain episodes [6]. Other pain
dimensions are quantitative (intensity) [7,8], qualitative* Correspondence: ingunn.mundal@gmail.com
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reproduction in any medium, provided the or(burning, pressing pain) [9], and spatial measures (whether
the pain is local, regional or widespread) [10-12]. Chronic
widespread pain (CWP) is an important measure of the
global burden of pain [1,13], with a reported prevalence of
4% to 18% [14,15]. These various aspects of chronic pain
have been assessed extensively and studied together as one
entity, but rarely separately. Wolfe et al. [16] have defined
CWP as pain in the left and right sides of the body, above
and below the waist, plus pain in the axial skeleton. CWP
seems to be more prevalent in females than in males
[17,18], but it appears to be constant between age groups,
and is associated with several complex medical conditionsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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appetite disturbances and fatigue [20].
Cross-sectional studies have demonstrated that different
pain characteristics are interrelated [21,22]. They have
examined the relation between CWP prevalence, demo-
graphic variables, lifestyle factors, and self-reported health
information [21,23,24], and have also reported that multi-
site pain problems are significantly associated with mood
and anxiety disorders, but not with alcohol abuse [25].
These factors are also assessed as risk factors of CWP onset
in population-based prospective studies [15,26-28]. A re-
cent review of risk factors associated with transitioning
from regional pain to CWP suggested that females, those of
older age, and those with a family history of pain and de-
pressed mood, were all at higher risk [29].
A few population-based prospective studies have exa-
mined predictive factors of CWP persistence associated
with CWP prevalence, suggesting that some 35% of those
with initial CWP, are likely to experience persistence when
they are females, of older ages, or exhibit additional phy-
sical or psychological symptoms [30,31]. In a three-year
follow-up study of pain distribution and risk factors,
Bergman and colleagues [32] found that the overall pre-
valence of CWP was persistent over a three-year period,
where 57% with initial CWP continued to have CWP at
follow-up. While CWP persistence was predicted by the
number of painful regions at baseline, as well by being an
immigrant, having personal social support and drinking
alcohol weekly seemed to be protective against persistence
[32]. A 5.5 year prospective study of a Norwegian female
population discovered that 61% with initial CWP continued
to have CWP at follow-up [33]. Psychological symptoms
were only assessed in one of these studies [30]. We are not
aware of any large prospective population-based study in-
vestigating mood, chronic disease, lifestyle and demo-
graphic factors together as predictors of long-term CWP
persistence. In view of the fact that CWP is closely asso-
ciated with negative bio-psychosocial consequences [34]
and mostly assessed in clinical samples, it is important to
obtain knowledge of the overall impact of factors that pre-
dict CWP persistence in the general population.
The aim of this study was to 1) assess the prevalence, and
2) analyse possible predictive health-related, lifestyle and
demographic factors as long-term predictive factors of CWP
persistence. We hypothesized that (i) anxiety, depression,
poor sleep, smoking and BMI ≥ 25 kg/m2 are predictors of
CWP persistence and that (ii) young age, male sex, alcohol
consumption and moderate exercise are protective factors.
Methods
Study population and baseline
This study is based on a large representative Norwegian co-
hort of individuals attending the second and third waves of
the Nord-Trøndelag Health Study (HUNT2 and HUNT3,respectively). The HUNT study (“Helseundersøkelsen i
Nord-Trøndelag”), designed as a longitudinal cohort study
consisting of three health surveys, was carried out three
times at 11 year intervals, in which all residents aged
20 years and older in Norway’s Nord-Trøndelag County
were invited to participate. The first survey (HUNT1) was
conducted between 1984 and 1986, while HUNT2 and
HUNT3 were performed in 1995–1997 and 2006–2008,
respectively. HUNT1 was designed primarily to cover four
sub-studies regarding hypertension, diabetes, lung diseases
and quality of life [35], while the scientific programme in
HUNT2 was extended to encompass large public health
issues, including mental health and chronic musculoske-
letal pain [36]. Pain data were not collected from HUNT1
and thus could not be included in this study. The health
data in all the studies were collected in the same way, by
interviews, self-administrated questionnaires and clinical
examinations. The majority of participants in all HUNT
surveys were middle aged or elderly (50 – 79 years) and
female [35].
This study includes those 20 years and older in age
(reaching 20 years during the year of screening in their
municipality) who attended both HUNT2 and HUNT3
[35]. Of those invited in HUNT2, a total of 65,237 (70%)
participated. In HUNT3 a total of 93,860 were eligible
for participation, where 50,807 (54%) participated [36].
Participation in each survey was defined as having filled
in questionnaire 1 (Q1), and a written consent form was
delivered with Q1 when the participants attended the
health examination sites. We included data collected
from Q1, Q2 and the health examination (such as body
mass index), and both questionnaires were distributed in
HUNT2 and HUNT3. Whereas Q1 was a self-reporting
questionnaire scored at home before attending the basic
health examination, Q2 was handed out after the clinical
examination and was to be completed at home and
returned by mail [36].
Because the baseline questions related to pain were
asked in Q1 in HUNT2 and the follow-up questions were
asked in Q2 in HUNT3, it was necessary to include all
subjects responding to both questionnaires in both
surveys. Hence, 28,367 individuals – 16,260 (57%) females
and 12,107 (43%) males – responded to Q1 and Q2 in
both HUNT2 and HUNT3, and these individuals con-
stituted the study population. Of these, 4,927 participants
reported CWP in HUNT2 and thus provided the baseline
sample (see Figure 1).
Dependent variable – CWP as reported in HUNT3
The chronicity of musculoskeletal pain was determined
by the participants responding positively with a “yes” on
the following question from the validated Standardized
Nordic Questionnaire (SNQ): “During the last year, have
you had pain and/or stiffness in your muscles and limbs
Participants in the 
HUNT2 cohort
Q1: 65,237 (70%)
Participants in the 
HUNT3 cohort       
Q1: 50,807 (54%)
Numbers of CWP in
HUNT2: 10,881(17%)
Invited to participate 
in HUNT2 cohort: 
93,898
Invited to participate in
HUNT3 cohort:
93,860
Participants attending 
both HUNT2-3 cohort:  
37, 071
STUDY population:              
Subjects attending both
HUNT2-3 cohort and Q1+ Q2
Participants: 28, 367
BASELINE sample HUNT2:
Subjects in the study sample
reporting Chronic Widespread
Pain: 4, 927 (17%)
Participants in the 
HUNT2 cohort
Q2: 55,384 (59%)
Participants in the 
HUNT3 cohort      
Q2: 41,203 (44%)
Numbers of CWP in
HUNT3: 7,084 (14%)
CWP in  HUNT2 not 
attending HUNT3 
2,451 (4%)
Participants with
missing values:
1,157 (23%)
Full participants with
complete values:
3,770 (77%)
Figure 1 Flowchart showing the inclusion of participants in the HUNT2 and HUNT3 study (Q1), the study population (participants
responding to both Q1 and Q2 in HUNT2 and HUNT3) and baseline sample (chronic widespread pain in HUNT2) calculated from the
study population. Q1: Questionnaire 1, Q1: Questionnaire 2.
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Those reporting chronic pain were invited to specify their
pain location(s) on a map of the human outer body [38].
The location included the following nine possible pain
sites: neck, shoulder, elbow, hand/wrist, upper back, lower
back, hip, knee and ankle/foot. If the participants res-
ponded “yes” to the introductory question but did not re-
spond to the follow-up location question, they were still
considered as having chronic pain, albeit not in the pic-
tured area. The outcome variable CWP was constructed
according to the Standardized Nordic Questionnaire and
the American College of Rheumatology’s (ACR) defined
criteria for CWP [39]. CWP in the present study was de-
fined as having chronic pain in all the following three
major body areas: the trunk (i.e. at least one of the fol-
lowing locations: neck, lower back, and/or upper back),lower limbs (i.e. at least one of the following: ankles, feet,
knees and/or hips), and upper limbs (i.e. at least one of
the following: shoulders, elbows and/or hands). As in the
original version of SNQ, the subjects in HUNT3 could
indicate bilateral bodily pain, but this information was
omitted because of the lack of ability to indicate bilateral
pain in HUNT2, where the baseline CWP variable was
computed. According to ACR’s abbreviated definition,
widespread pain is described as axial pain, left- and right-
side pain, and upper- and lower-segment pain [39]. Pain
in the left or right shoulder and buttock was considered as
pain in each side, and lower-back pain was considered as
lower-segment pain [16]. Thus, CWP was defined as the
presence of pain in all four quadrants of the body. We
analysed the CWP as a categorical variable, with cate-
gories 0 and 1.
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The independent variables were sex and baseline informa-
tion on age, separate anxiety and depression measures from
the Hospital Anxiety and Depression Scale (HADS), alco-
hol use, insomnia and body mass index (BMI). Variables
also included smoking status, marital status, education, ex-
ercise, and chronic disease, all of which were observed in
the HUNT2 period. HADS is a well-established and vali-
dated 14-item, self-rating questionnaire that aims to detect
general symptoms of anxiety and depression. It comprises
seven items for depression (HADS-D) and seven for anx-
iety (HADS-A), in which each item includes a four-point
Likert-scale response category (0–3) [40,41]. A mixed
HADS variable was constructed and categorized into four
groups: neither anxiety nor depression, pure depression,
pure anxiety, and both depression and anxiety. The cut-off
score of ≥ 8 was set to define the caseness of having anxiety
or depression, and a cut-off score of ≥ 8 on each indicated
the caseness of having both anxiety and depression [40,42].
In this study we wanted to examine the concurrence of
anxiety and/or depression symptoms in relation to the
scope of musculoskeletal pain rather than identifying the
actual caseness of having anxiety and/or depression. How-
ever, the cut-offs were set to mark the borderline of depres-
sion or anxiety or both, even though a structured clinical
interview, e.g. SCID-I, is the golden standard in clinical set-
tings [43]. Because data from alcohol screening tools could
not adequate reflect problems with alcohol, we decided to
use data related to the frequency of alcohol use. The fre-
quency of alcohol consumption was identified by two ques-
tions: “Concerning alcohol, are you a non-drinker?” and
“how many times a month do you normally drink alcohol?”
Responses were categorized as 1) abstainer, 2) drinking 0
times a month, 3) drinking 1–7 times a month, or 4) drink-
ing 8 times or more a month. Drinking alcohol 0 times a
month indicates a person that rarely drinks alcohol, but is
not the same as a non-drinker by principle.
The influences that sleeping problems had on the
CWP outcome were examined by using three questions
from Q2, each related to non-restorative sleep, difficul-
ties of sleep onset, and problems of maintaining sleep.
Non-restorative sleep was identified by asking “how
often do you suffer from insomnia?”, where the response
options included “never or a few times a year”, “1–2
times a month”, “about once a week” and “more than
once a week”. Problems of sleep onset and maintaining
sleep were measured by two questions: “Have you had
difficulty falling asleep in the last month?” and “during
the last month, have you woken too early and not been
able to get back to sleep?” Response options included
“almost every night”, “often”, “now and again” and “never”,
where the responses “almost every night” and “often” were
defined as problems (1) and “now and again” and “never”
as no problems (0). The three variables of “non-restorativesleep”, “sleep onset” and “maintaining sleep” were com-
bined into one variable reflecting sleeping problems and
categorized as “no problem” or “problem” (i.e. reporting 1
or more sleeping problems on the 3 items). According
to the cut-offs recommended from the World Health
Organization’s Global Database on Body Mass Index, [44],
BMI was computed from the height and weight measure-
ments and categorized into four groups as: underweight
(BMI < 18.5 kg/m2), normal (BMI 18.5–24.9 kg/m2), over-
weight (BMI 25–29.9 kg/m2) and obese (BMI ≥ 30 kg/m2).
Smoking was identified by using a constructed variable of
smoking status categorized into “never smoking”, “previous
smoking” and “current smoking”. Data on marital status
and age were provided from the National Population
Registry. Marital status was categorized into two groups:
“single/divorced/separated/widower” and “married/coha-
bitant/partnership”. Education level was specified in three
categories: “primary school”, “high-school” and “university/
college of four years or more”. Physical exercise was mea-
sured through two variables of light and hard duration as:
“average of hours of both light and hard physical activity
per week in the last year” and reflected “no” up to “moder-
ate” levels of physical activity. Long-term illness (chronic
disease) was evaluated by the question “do you suffer from
any long-term illness or injury of a physical or psychological
nature that impairs your functioning in everyday life?”
where “long term” means at least one year. The response
options were “yes/no”. The “no pain” group in the study
population covered all subjects that did not satisfy the
CWP criteria, including those that responded “yes” to the
introductory question on pain but did not indicate the site
of pain. The sex ratios were calculated by dividing female
prevalence by male prevalence.Statistical analysis
Two models were used to examine predictors of CWP
persistence. The examination of each was performed
through logistic regression analyses resulting in odds ratios,
with 95% confidence intervals. Model 1 captured the results
from each variable of interest in a crude age- and sex-
adjusted analysis. In model 2, all variables were included in
one multivariable model. Because some variables were
missing observations, only complete cases were included in
the regression analyses. Missing observations concerned
1,157 respondents (23%) from the baseline sample. The
analyses were examined for statistical interactions between
sex and the independent variables. All data were analysed
by using Stata 12.1 for Windows (Stata Corporation, USA).Ethics
This study was approved by the Board of Research Ethics
in Health Region IV of Norway and the National Data
Inspectorate.
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Of the 28,367 subjects who completed the introductory
question on chronic musculoskeletal pain, 28,313 subjects
were included in HUNT2 and 27,574 were included in
HUNT3. The overall mean age in the HUNT2 cohort was
50.1 years (SD 17.2), ranging from 19.1 to 101.1 years,
while the mean age in the HUNT3 cohort was 53.1 years
(SD 16.1), ranging from 19.0 to 100.8 years (data not
shown). The mean age in the baseline sample (CWP in
HUNT2) was 52.3 years (SD 11.4), varying between 19.5
to 85.9 years. The age distribution frequency of the base-
line sample showed that the majority of the participants
(59%) were aged 40 to 59 years. The mean baseline HADS
depression and anxiety scores were 4.42 (SD 3.32) and
5.50 (SD 3.7), respectively, versus 3.49 (SD 3.1) and 4.24
(SD 3.4), respectively, in the study population (data not
shown). Descriptive data on the variables of interest are
described in Table 1.
The mean HADS scores in the HUNT2 study popu-
lation were similar to the mean HADS scores in the
HUNT2 cohort. Only 0.4% of the study population re-
ported chronic musculoskeletal pain without specifying
any pain location.
Prevalence of persistent chronic widespread pain after
11 years
Of those reporting CWP in HUNT2 (i.e. baseline = 17%),
53% (n = 1,997) still reported CWP in the HUNT3 follow-
up, and 74% of these were females. By comparison, the
overall female proportion in the study population was
57%.
Regression results
Crude analysis
From the health-related variables in the unadjusted ana-
lysis (see Table 2), symptoms of depression (OR: 1.28, 95%
confidence interval (CI): 0.96–1.69) indicated a weak in-
crease in CWP persistence. Symptoms of anxiety showed
a 35% increased odds of CWP (OR: 1.35, 95% CI: 1.12–
1.62), while symptoms of mixed anxiety and depression
showed a 48% increased odds of CWP persistence (OR:
1.46, 95% CI: 1.19–1.82), versus the absence of anxiety
and depression symptoms. Similarly, sleeping problems
showed an increased CWP persistence compared with no
sleeping problems (OR: 1.49, 95% CI: 1.30–1.71). Those
with a chronic disease had almost twice the odds of CWP
persistence compared to those without a chronic disease
(OR: 1.89, 95% CI: 1.66–2.16).
Compared with never smokers, former smokers were at
greater risk of CWP persistence (OR: 1.23, 95% CI: 1.05–
1.45), while current smokers differed only marginally from
never smokers (OR: 1.14, 95% CI: 0.97–1.33). Compared
with study participants with normal weight, obese partici-
pants had higher odds of CWP persistence (OR: 1.68, 95%CI: 1.39–2.02). Drinking alcohol 8 times or more a month
(OR: 0.85, 95% CI: 0.60–1.21) showed a non-substantial
protective tendency when compared with abstainers.
Participants 60 years or older had a lower odds of CWP
persistence (OR: 0.76, 95% CI: 0.62–0.93) compared with
the youngest age group (age 20–39). Also, those with an
education at the university/college level had a lower odds
of CWP persistence (OR: 0.76, 95% CI: 0.62–0.93) than
those with a primary education only. Males had about half
the odds of CWP persistence (OR: 0.53, 95% CI: 0.46–
0.61) compared with females.
Adjusted analysis
In the adjusted analysis, symptoms of anxiety (OR: 1.24,
95% CI: 1.02–1.50) and mixed anxiety and depression (OR:
1.18, 95% CI: 0.95–1.47) only indicated a weak increase in
CWP persistence. Sleeping problems remained a substan-
tial predictor of CWP persistence (OR: 1.30, 95% CI: 1.12–
1.51), compared with the lack of sleeping problems. Those
with a chronic disease had a 75% increased odds of CWP
persistence (OR: 1.75. 95% CI: 1.53–2.01) compared with
participants without a chronic disease. Adjusted for the
other possible predictors, overweight participants had a
weak increased odds of CWP persistence (OR: 1.18, 95%
CI: 1.01–1.32) while obese participants had a 66% in-
creased odds of CWP persistence (OR: 1.66, 95% CI: 1.37–
2.01) compared with normal weight individuals. Former
smokers had a weak increase in CWP persistence (OR:
1.18, 95% CI: 1.00–1.39) compared with never smokers.
Compared with the youngest age group (age 20–39), study
participants 60 years or older showed a reduced odds of
CWP persistence (OR: 0.63, 95% CI: 0.50–0.81), and males
had about half the odds of CWP persistence (OR: 0.51,
95% CI: 0.44–0.59) compared to females. All results, both
crude and adjusted models, are presented in Table 2.
Comparison of HUNT3 non-participants and participants
with CWP in HUNT2
Some participants experienced CWP in HUNT2, but did
not attend HUNT3 (n = 2,451). To obtain descriptive mea-
sures, these HUNT3 non-participants were compared to
the HUNT3 participants who had CWP in HUNT2, i.e.
the baseline sample (n = 4,927). The mean age of non-
participants was 54.4 years (SD 15.7). Compared to the
baseline sample, non-participants were more likely to be
obese, have sleeping problems and smoke daily. There were
also group differences in age distribution, education, mari-
tal status and chronic disease. The results are presented in
Table 3.
Statistical interaction analyses
Statistical interaction analyses indicated weak evidence
of statistical interaction between sex and the other
evaluated variables (p > 0.12).
Table 1 Sample characteristics of the study population and baseline sample (Widespread pain in HUNT2)
Study population *Baseline sample Female Male
N = 28,367 (%)§ N = 4,927 (%)§ N = 3,372 (68.4) N = 1,555 (31.6)
Sex Females (%) 16,260 (57)
Males (%) 12,107 (43)
Age in years, mean (SD) 47.6 (13.3) 52.3 (11.4) 51.7 (11.5) 53.7 (11.1)
20-39, (%) 8,397 (30) 733 (15) 558 (17) 175 (11)
40-59 24,664 (50) 2,892 (59) 1,996 (59) 896 (58)
60 years or older 5,707 (20) 1,302 (26) 818 (24) 484 (31)
HADS score; (%)
HADS, (%) score < 8, 22,560 (81) 3,209 (67) 2,130 (65) 1,079 (71)
HADS-D, cut off score≥ 8, 1,124 (4) 300 (6) 167 (5) 133 (9)
HADS-A, cut off score≥ 8, 2,672 (10) 754 (16) 583 (18) 171 (11)
HADS-mixed 1,451 (5) 530 (11) 389 (12) 141 (9)
Sleeping difficulties (%)
No problems 21,597 (81) 2,929 (63) 1,899 (59) 1,030 (70)
Problems 5,195 (19) 1,751 (37) 1,319 (41) 432 (30)
Alcohol use – abstainers (%) 2,546 (9) 552 (12) 444 (14) 108 (7)
0 times/month 7,256 (27) 1,516 (32) 1,156 (36) 360 (24)
1-7 times/month 15,790 (58) 2,398 (51) 1,488 (46) 910 (61)
8≥ times/month 1,718 (6) 240 (5) 123 (4) 117 (8)
BMI (%)
Underweight 150 (1) 23 (1) 20 (1) 3 (0.2)
Normal 11,378 (40) 1,593 (32) 1,189 (35) 404 (26)
Overweight 12,606 (45) 2,262 (46) 1,394 (41) 868 (56)
Obesity 6,984 (25) 1,040 (21) 761 (23) 279 (18)
Smoking status, (%)
Never smoked 12,912 (46) 1,759 (36) 1,315 (39) 444 (29)
Former smoker 8,249 (29) 1,612 (33) 940 (29) 672 (44)
Current smoker 6,984 (25) 1,517 (31) 1,089 (28.2) 428 (28)
Exercise, moderate (%)
No exercise 16,123 (60) 2,974 (65) 2,044 (66) 932 (63)
Moderate exercise 10,731 (40) 1,575 (35) 1,035 (34) 540 (37)
Education in years (%)
Primary school (%) 8,678 (31) 2,129 (45.6) 1,562 (48) 617 (41)
High school 12,649 (46) 1,946 (40.7) 1,229 (38) 717 (47)
College 6,435 (23) 653 (13.7) 472 (14) 181 (12)
Marital status (%)
Not married/cohabitant 8,620 (30) 1,226 (25) 882 (26) 344 (22.2)
Married/cohabitant 19,694 (70) 3,690 (75) 2,482 (74) 1,208 (78)
Chronic disease, (%)
No 21,018 (77) 2,156 (47) 1,527 (49) 629 (42)
Yes 6,116 (23) 2,418 (53) 1,566 (51) 852 (58)
§N in Study population will vary due to missing data.
*Calculated from the study population N = 28,367 (respondents of BOTH questionnaires Q1 and Q2 in HUNT2 and HUNT3).
N will vary slightly because of missing data.
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Table 2 Odds ratios (ORs) with 95% confidence intervals (CIs) for persistent chronic widespread pain in HUNT3
Baseline variables HUNT2 N = 3,770 CWP in HUNT3 N = 1,997 Model 1 – crude model Model 2 – adjusted model
N (%) OR [95% CI] OR [95% CI]
Sex Female [ref.] 2,540 (67) 1,447 (74) 1.00 1.00
Male 1,230 (33) 520 (26) 0.53 [0.46-0.61] 0.51 [0.44-0.59]
Age, 20–39 yrs [ref.] 643 (17) 342 (17) 1.00 1.00
Age, 40–59 yrs (<40 yrs [ref.]) 2,388 (63) 1,323 (66) 1.12 [0.94-1.34] 1.03 [0.85-1.25]
≥60 yrs 739 (20) 332 (17) 0.76 [0.62-0.94] 0.63 [0.50-0.81]
HADS (A/D <8 [ref.]) 2,544 (67) 1,276 (64) 1.00 1.00
HADS Depression (D) ≥8 220 (6) 120 (6) 1.28 [0.96-1.69] 1.12 [0.84-1.50]
Anxiety (A) ≥8 578 (15) 343 (17) 1.35 [1.12-1.62] 1.24 [1.02-1.50]
Depression ≥8 AND Anxiety ≥8 428 (11) 260 (13) 1.48 [1.19-1.82] 1.18 [0.95-1.47]
Sleep problems, never [ref.] 2,544 (64) 1,195 (60) 1.00 1.00
Often 1,345 (36) 802 (40) 1.49 [1.30-1.71] 1.30 [1.12-1.51]
Smoke status, never smoking [ref.] 1,315 (35) 667 (33) 1.00 1.00
Ex. smoker 1,235 (33) 665 (33) 1.23 [1.05-1.45] 1.18 [1.00-1.39]
Current daily smoker 1,220 (32) 665 (33) 1.14 [0.97-1.33] 1.10 [0.93-1.31]
BMI normal 18.5-24.9 kg/m2 [ref.] 1,262 (33) 633 (32) 1.00 1.00
Underweight <18.5 kg/m2 21 (0.6) 7 (0.35) 0.46 [0.18-1.15] 0.43 [0.17-1.10]
Overweight 25–29.9 kg/m2 1,730 (46) 893 (45) 1.17 [1.01-1.36] 1.18 [1.01-1.37]
Obese ≥30 kg/m2 757 (20) 464 (23) 1.68 [1.39-2.02] 1.66 [1.37-2.01]
Alcohol-monthly use, abstainers [ref.] 375 (10) 205 (10) 1.00 1.00
0 time a month 1,139 (30) 615 (31) 0.94 [0.74-1.20] 0.97 [0.76-1.24]
1-7 times a month 2,046 (54) 1,077 (54) 0.95 [0.76-1.19] 1.01 [0.79-1.28]
8 times or more a month 210 (6) 100 (5) 0.85 [0.60-1.21] 0.90 [0.62-1.29]
Education, primary school, [ref.] 1,546 (41) 824 (41) 1.00 1.00
High school 1,661 (44) 900 (45) 1.03 [0.89-1.20] 1.10 [0.94-1.28]
University/college 563 (15) 273 (14) 0.76 [0.62-0.93] 0.86 [0.70-1.06]
Exercise, low/no [ref.] 2,487 (66) 1,338 (67) 1.00 1.00
Moderate 1,283 (34) 659 (33) 0.94 [0.82-1.07] 0.97 [0.84-1.12]
Marital status - single [ref.] 925 (25) 505 (25) 1.00 1.00
Married 2,845 (75) 1,492 (75) 0.92 [0.79-1.07] 0.94 [0.80-1.10]
Disease Chronic, no [ref.] 1,806 (48) 830 (42) 1.00 1.00
Yes 1,964 (52) 1,167 (58) 1.89 [1.66-2.16] 1.75 [1.53-2.01]
Model 1: Crude – age and sex adjusted.
Model 2: All variables included.
Only complete cases included.
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In this large prospective cohort study, 53% of the
participants with baseline CWP still had CWP at follow-up.
According to the adjusted model, we found strong positive
associations over time between persistent CWP and sleeping
problems, being obese and having a chronic disease, while
anxiety, mixed anxiety and depression symptoms, former
smoking and being overweight showed weaker positive
associations with persistent CWP 11 years later. Being a
male and being 60 years of age were substantial protective
factors against long-term persistent CWP.Strengths and weaknesses
Strengths
A major strength of this study was its large population
base, its acceptable participation rate and its long-term
follow-up. The study also contained a robust design and a
lot of variables for comparing between different follow-up
times. The pain measures were gauged with validated,
well-known and standardized questionnaires that rely on
self-reporting [1], which also would allow for reliable com-
parisons. By allowing the respondents to select individual
body pain sites, we obtained a picture of the extent and
Table 3 Comparison of measures of non-participantsa in
HUNT3 with CWP in HUNT2, and the baseline sampleb
aNon-participants
HUNT3
N = 2,451(%)§
bBaseline sample
HUNT2
N = 4,927 (%)§
Sex Females (%) 1,634 (67) 3,372 (68)
Males (%) 817 (33) 1,555 (32)
Age in years, mean (SD) 54.4 (15.7) 52.3 (11.4)
20-39, (%) 513 (21) 733 (15)
40-59 964 (39) 2,892 (59)
60 years or older 974 (40) 1,302 (26)
HADS score; (%)
HADS, (%) score < 8, 1,426 (63) 3,209 (67)
HADS-D, cut off score≥ 8, 141 (6) 300 (6)
HADS-A, cut off score≥ 8, 374 (16) 754 (16)
HADS-mixed 327 (14) 530 (11)
Sleeping difficulties (%)
No problems 834 (53) 2,929 (63)
Problems 759 (47) 1,751 (37)
Alcohol use – abstainers (%) 396 (17) 552 (12)
0 times/month 775 (34) 1,516 (32)
1-7 times/month 1,017 (45) 2,398 (51)
8≥ times/month 91(4) 240 (5)
BMI (%)
Underweight 19 (1) 23 (1)
Normal 279 (30) 1,593 (32)
Overweight 1,034 (43) 2,262 (46)
Obesity 634 (26) 1,040 (21)
Smoking status, (%)
Never smoked 749 (31) 1,759 (36)
Former smoker 637 (27) 1,612 (33)
Current smoker 1,004 (42) 1,517 (31)
Exercise, moderate (%)
No exercise 1,378 (66) 2,974 (65)
Moderate exercise 699 (34) 1,575 (35)
Education in years (%)
Primary school (%) 1,251 (55) 2,129 (45.6)
High school 796 (35) 1,946 (40.7)
College 211 (9) 653 (13.7)
Marital status (%)
Not married/cohabitant 941 (38) 1,226 (25)
Married/cohabitant, 1,509 (62) 3,690 (75)
Table 3 Comparison of measures of non-participantsa in
HUNT3 with CWP in HUNT2, and the baseline sampleb
(Continued)
Chronic disease, (%)
No 873 (39) 2,156 (47)
Yes 1,345 (61) 2,418 (53)
§N will vary due to missing data.
aParticipants with CWP attending HUNT2 cohort but not attending HUNT3.
bBaseline Sample (respondents with CWP in HUNT2 and responding to
BOTH questionnaires.
Q1 and Q2 in HUNT2 and HUNT3.
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ing the pain’s breadth. This study examined pain only by
pain duration and pain location (i.e. CWP) but not by pain
intensity or temporal features, and thus the study did not
differentiate between intermittent, fluctuating or continu-
ous pain, nor if the pain was disease related [45].
Weaknesses
Defining chronic pain only by duration and location,
but not by pain intensity or severity may weaken the
study’s optimality. In epidemiologic studies of pain,
which are often based on self-report questionnaires ra-
ther than clinical findings, the complex nature of
chronic pain represents a major challenge for the study’s
validity. Another weakness is that the participation rate
decreased in the last HUNT study, as it does in most
longitudinal population-based cohort studies. The attri-
tion was 15% and was most pronounced among males
and younger adults. A non-participant study based upon
the HUNT2 study revealed that being abroad and the
lack of time for scoring were the main reasons for non-
attendance for people aged 20–44 years [36]. Decreased
participation rates might threaten the internal validity
in population-based studies [46]. In this study, the non-
participants were likely to be older and less educated,
experience sleeping problem and a chronic disease, and
smoke on a daily basis. In general, non-participation in
HUNT3 was characterized by lifestyle factors regarding
smoking and physical inactivity, along with higher
prevalence of several chronic diseases [46], which is in
line with our findings. However, the participation rate
for age groups 60 – 80 years in HUNT 3 were 65% to
70% compared to the overall participation rate of 54%.
We also believe that having the option to indicate
bilateral pain at baseline, might have affected the sample
size and thus the outcome. Meeting the ACR criteria of
CWP by having chronic pain in all three major body
areas paired with the option to indicate pain in both
sides, may have resulted in a lower prevalence of base-
line CWP and may have indicated a more severe pain
condition. However, the baseline in this study covers all
responders with CWP, including those with bilateral
pain.
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Although this rather large study indicates that CWP
occurs frequently in the general population, the conditions
within CWP do not necessarily appear as invariable or un-
changing, and with time, the individuals could move
through various categories of chronic pain syndrome [47].
In this study a few factors point to pain persistence. Sev-
eral factors not included in the HUNT2 study might
explain why 53% of the baseline CWP persisted at follow-
up. Lacking the possibility to indicate pain intensity and
bilateral pain, which might indicate a level the pain condi-
tion’s severity, could be one factor. In addition, detailed
information on social aspects might be of interest in this
context. Likewise, more detailed information on medical
treatment such as analgesics, which the HUNT2 survey
roughly offered, or comorbid conditions, could be of inter-
est for explaining pain persistence. Data on medication
were, however, omitted due to incomplete responses.
Yet, a substantial number of subjects at baseline (47%)
changed from having CWP at baseline to not having CWP
at follow-up. The fact that a large proportion of the general
population actually does resolve from CWP is additional
knowledge for pain research and treatment. This finding is
in contrast with other studies showing that the overall
prevalence of CWP is stable over time and that pain is
likely to persist if accompanied by, for example somatic
symptoms and older age [31,32]. Our results may partly
derive from investigating the general population in an 11-
year longitudinal follow-up study. Another reason may be
due to another important finding, namely that CWP preva-
lence decreased among those at 60 years and older. This
means that participants in their 50s at baseline would ac-
cordingly be in their 60s at follow-up, thus entering an age
group associated with decreasing CWP. According to the
present study, aging was not associated with an increased
likelihood of persistent CWP. Instead, aging appeared to
be a protective factor against chronicity, despite the fact
that some rheumatic diseases, for example, occur at older
ages. Still, it make senses to assume that the high preva-
lence of CWP (17%) in this study may be related to the age
distribution and the mean age of the HUNT cohort and
the baseline sample, and the fact that CWP mainly affects
middle-aged and older females and males [47,48]. These
findings could indicate that CWP among the older popula-
tion is poorly understood and mainly studied as a key
symptom in fibromyalgia [39,47-50]. Associations between
aging and pain are multidimensional, and at old(er) ages
the problem of pain is considered to be highly complex
due to multiple comorbidities [51]. Although multi-
morbidity becomes more common with age, more than
the half those with multi-morbidity and nearly two-thirds
with physical–mental health comorbidity are younger than
65 [52]. Our study revealed that having other chronic dis-
eases was the strongest predictor of CWP persistence. Sexdifferences in pain reporting have been ascribed to a range
of factors: e.g. pain perception factors such as menstrual
cycle variations in pain sensitivity in younger females [48],
the greater likelihood for females to visit a physician and to
report long-lasting pain, the lower pain threshold among
females and their greater prevalence of having pain related
to autoimmune disease [18]. Males and females at older
ages also differ in many of these factors [48,53]. Likewise,
age-related sex differences may be due to biological (e.g.
gonadal hormones) and psychosocial factors (e.g. older
people are more exposed to depression, life cycle changes,
etc.), as well as multi-morbidity as a part of aging [51],
which means a shift in attention from pain to other condi-
tions. A previous study [47] reported that the prevalence of
CWP peaks at midlife and then slowly decreases. Another
study [32] found that the highest prevalence of CWP was
among those of 59–74 years of age. In line with other stud-
ies, we found a female over-representation both in the
baseline sample (2:1) and among the respondents with per-
sistent CWP at follow-up (3:1). The most frequently stated
ratio for chronic musculoskeletal pain and CWP in males
and females is that females are about 1 ½ times more likely
to experience both chronic musculoskeletal pain and CWP
[49]. We found that only sleeping problems was associated
with persistent pain in females, just as only former smok-
ing was associated with persistent pain in males. Except
from the sex ratio and in terms of prognostic factors, we
did not find specific sex differences among those with
CWP at baseline.
Depression and anxiety disorders are commonly reported
co-morbid conditions in CWP [26,29,47,54-57]. These are
usually based on cross-sectional and clinical samples rather
than prospective community subjects. Clauw and Crofford
[49] suggested that by examining CWP in population-based
studies, the bias from using clinical patient samples would
be removed and CWP would be much similar to other
chronic pain syndromes. In our large population-based
study, we hypothesized that symptoms of anxiety and/or de-
pression would predict the persistence of CWP at the 11-
year follow-up. However, we found only weak associations
between symptoms of anxiety and mixed anxiety and depres-
sion and persistent CWP. Because depressive symptoms
overlap with somatic symptoms in chronic pain conditions,
depressive disorders could be over-diagnosed in people with
chronic pain [58]. Likewise, it is possible that we were unable
to reach those with severe pain or that the respondent’s pain
could be perceived as mild despite the chronicity and
breadth or underlying musculoskeletal disease. Although
these conditions often cause severe pains, knowing the origin
of the pain and/or having an opportunity to receive adequate
treatment could influence how the subjects deal with suffer-
ing from a long-standing chronic pain condition. According
to Dersh and colleagues [59], there are several reasons for
considering chronic pain and mood disorders as distinct
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may share common factors. The onset of pain and mild psy-
chological disturbances do not typically coincide, and each
condition could be mutually independent for many individ-
uals [59]. While those with chronic pain and psychological
distress frequently tend to consult health services, not all
those with chronic pain experience psychological distress as
anxiety or depression [60], which might explain the weak as-
sociations in our study. Considering BMI, only obesity had a
substantial effect on persistent CWP. According to several
prospective studies, being overweight and obese are risk fac-
tors for chronic pain because weight gains increases bodily
strains, especially strains in joints [61-63]. Our findings sup-
port a previous study reporting that CWP is significantly as-
sociated with obesity alone, but weakly associated with being
overweight [63].
Conclusion
The results demonstrated that many respondents (53%) in
the general population maintained CWP, but a large propor-
tion (47%) also resolved within an 11-year period. Persistent
CWP was examined in association with important cofactors
suggested by previous research. The study revealed strong
positive associations over time with sleeping problems, obes-
ity and chronic disease, while being 60 years or older was
protective. Contrary to other studies, depression, anxiety and
the frequency of alcohol consumption were not substantial
predictors of outcome. Except from the sex differences in
prevalence, the adjusted analyses revealed no prominent sex
differences related to the predictors or protectors of CWP
persistence. This large prospective population-based study
brings new knowledge about what is important for long-
term CWP persistence. Additional prospective population
studies could reveal predictive factors for why many CWP
individuals recover and why others do not recover from
pain.
Competing interests
The authors declare no conflict of interest.
Authors’ contributions
IM was responsible for collecting and analysing data and manuscript
drafting. RWG, OML and EAF contributed to the study’s conception, as well
critical revision and manuscript drafting. JHB was involved in the data
analysis and statistical interpretation, and contributed in particular with
methodical and epidemiological support and critical revision and manuscript
revising and drafting. All authors have made substantial intellectual
contributions and read and approved the final manuscript.
Acknowledgements
The Nord-Trøndelag Health Study (The HUNT Study) is the collaboration
between HUNT Research Centre (Faculty of Medicine, Norwegian University
of Science and Technology NTNU), Nord-Trøndelag County Council, Central
Norway Health Authority, and the Norwegian Institute of Public Health.
Author details
1Department of Neuroscience, Faculty of Medicine, Norwegian University of
Science and Technology, 7491 Trondheim, Norway. 2Outpatient Department
of Psychiatry, Kristiansund Hospital, Møre and Romsdal Hospital Trust,
Kristiansund, Norway. 3Department of Research and Development, AddictionMedicine, St. Olav’s University Hospital, Trondheim, Norway. 4Department of
Public Health and General Practice, Faculty of Medicine, Norwegian
University of Science and Technology, Trondheim, Norway. 5Forensic
Department and Research Centre Bröset, St Olav’s University Hospital,
Trondheim, Norway. 6Department of Psychiatry, Department of Research and
Development, St Olavs University Hospital, Trondheim, Norway. 7Department
of Psychiatry, St Olavs University Hospital, Trondheim, Norway.
Received: 22 August 2013 Accepted: 10 June 2014
Published: 20 June 2014
References
1. Croft P, Blyth FM, van der Windt D: The global occurence of chronic pain.
An introduction. Chronic Pain Epidemiology. From Aetiology to Public Health.
New York: Oxford University Press; 2010:9–18.
2. Neville A, Peleg R, Singer Y, Sherf M, Shvartzman P: Chronic pain:
a population-based study. Isr Med Assoc J 2008, 10(10):676–680.
3. Portenoy RK, Ugarte C, Fuller I, Haas G: Population-based survey of pain in
the United States: differences among white, African American, and
Hispanic subjects. J Pain 2004, 5(6):317–328.
4. Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC, Borges GL,
Bromet EJ, Demytteneare K, de Girolamo G, de Graaf R, Gureje O, Lepine JP,
Haro JM, Levinson D, Oakley Browne MA, Posada-Villa J, Seedat S, Watanabe
M: Common chronic pain conditions in developed and developing
countries: gender and age differences and comorbidity with depression-
anxiety disorders. J Pain 2008, 9(10):883–891.
5. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D: Survey of chronic
pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain
2006, 10(4):287–333.
6. Vellucci R: Heterogeneity of chronic pain. Clin Drug Investig 2012,
32(Suppl 1):3–10.
7. Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH,
Fainsinger R, Aass N, Kaasa S, European Palliative Care Research C: Studies
comparing numerical rating scales, verbal rating scales, and visual
analogue scales for assessment of pain intensity in adults: a systematic
literature review. J Pain Symptom Manage 2011, 41(6):1073–1093.
8. Jensen MP, McFarland CA: Increasing the reliability and validity of pain
intensity measurement in chronic pain patients. Pain 1993, 55(2):195–203.
9. Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS:
Do pain qualities and spatial characteristics make independent
contributions to interference with physical and emotional functioning?
J Pain 2006, 7(9):644–653.
10. Andersson HI: The course of non-malignant chronic pain: a 12-year
follow-up of a cohort from the general population. Eur J Pain 2004,
8(1):47–53.
11. Carnes D, Parsons S, Ashby D, Breen A, Foster NE, Pincus T, Vogel S,
Underwood M: Chronic musculoskeletal pain rarely presents in a single
body site: results from a UK population study. Rheumatology (Oxford)
2007, 46(7):1168–1170.
12. Kamaleri Y, Natvig B, Ihlebaek CM, Benth JS, Bruusgaard D: Change in the
number of musculoskeletal pain sites: A 14-year prospective study.
Pain 2009, 141(1–2):25–30.
13. Blyth FM: Chronic pain–is it a public health problem? Pain 2008,
137(3):465–466.
14. Lindell L, Bergman S, Petersson IF, Jacobsson LT, Herrstrom P: Prevalence of
fibromyalgia and chronic widespread pain. Scand J Prim Health Care 2000,
18(3):149–153.
15. McBeth J, Nicholl BI, Cordingley L, Davies KA, Macfarlane GJ: Chronic
widespread pain predicts physical inactivity: results from the prospective
EPIFUND study. Eur J Pain 2010, 14(9):972–979.
16. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL,
Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber S, Fiechtner JJ,
Franklin CM, Gatfer RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, Mccain
GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American college
of rheumatology 1990 criteria for the classification of fibromyalgia.
Report of the multicenter criteria committee. Arthritis Rheum 1990,
33(2):160–172.
17. Greenspan JD, Craft RM, LeResche L, Arendt-Nielsen L, Berkley KJ, Fillingim
RB, Gold MS, Holdcroft A, Lautenbacher S, Mayer EA, Mogil JS, Murphy AZ,
Traub RJ: Studying sex and gender differences in pain and analgesia:
a consensus report. Pain 2007, 132(Suppl 1):S26–S45.
Mundal et al. BMC Musculoskeletal Disorders 2014, 15:213 Page 11 of 12
http://www.biomedcentral.com/1471-2474/15/21318. Hurley RW, Adams MC: Sex, gender, and pain: an overview of a complex
field. Anesth Analg 2008, 107(1):309–317.
19. Thomas E, Peat G, Harris L, Wilkie R, Croft PR: The prevalence of pain and
pain interference in a general population of older adults: cross-sectional
findings from the North Staffordshire Osteoarthritis Project (NorStOP).
Pain 2004, 110(1–2):361–368.
20. Ohayon MM, Schatzberg AF: Using chronic pain to predict depressive
morbidity in the general population. Arch Gen Psychiatry 2003,
60(1):39–47.
21. Hagen K, Linde M, Heuch I, Stovner LJ, Zwart JA: Increasing prevalence
of chronic musculoskeletal complaints. A large 11-year follow-up
in the general population (HUNT 2 and 3). Pain Med 2011,
12(11):1657–1666.
22. Smith BH, Macfarlane GJ, Torrance N: Epidemiology of chronic pain, from
the laboratory to the bus stop: time to add understanding of biological
mechanisms to the study of risk factors in population-based research?
Pain 2007, 127(1–2):5–10.
23. Hitt HC, McMillen RC, Thornton-Neaves T, Koch K, Cosby AG: Comorbidity
of obesity and pain in a general population: results from the Southern
Pain Prevalence Study. J Pain 2007, 8(5):430–436.
24. Vandenkerkhof EG, Macdonald HM, Jones GT, Power C, Macfarlane GJ: Diet,
lifestyle and chronic widespread pain: results from the 1958 British birth
cohort study. Pain Res Manag 2011, 16(2):87–92.
25. Gureje O, Von Korff M, Kola L, Demyttenaere K, He Y, Posada-Villa J, Lepine
JP, Angermeyer MC, Levinson D, de Girolamo G, Iwata N, Karam A,
Guimaraes Borges GL, de Graaf R, Browne MO, Stein DJ, Haro JM, Bromet EJ,
Kessler RC, Alonso J: The relation between multiple pains and mental
disorders: results from the World Mental Health Surveys. Pain 2008,
135(1–2):82–91.
26. Gupta A, Silman AJ, Ray D, Morriss R, Dickens C, MacFarlane GJ, Chiu YH,
Nicholl B, McBeth J: The role of psychosocial factors in predicting the
onset of chronic widespread pain: results from a prospective population-
based study. Rheumatology (Oxford) 2007, 46(4):666–671.
27. Nicholl BI, Macfarlane GJ, Davies KA, Morriss R, Dickens C, McBeth J:
Premorbid psychosocial factors are associated with poor health-related
quality of life in subjects with new onset of chronic widespread pain -
results from the EPIFUND study. Pain 2009, 141(1–2):119–126.
28. Davies KA, Macfarlane GJ, Nicholl BI, Dickens C, Morriss R, Ray D, McBeth J:
Restorative sleep predicts the resolution of chronic widespread pain:
results from the EPIFUND study. Rheumatology (Oxford) 2008,
47(12):1809–1813.
29. Larsson B, Bjork J, Borsbo B, Gerdle B: A systematic review of risk factors
associated with transitioning from regional musculoskeletal pain to
chronic widespread pain. Eur J Pain 2012, 16(8):1084–1093.
30. MacFarlane GJ, Thomas E, Papageorgiou AC, Schollum J, Croft PR, Silman AJ:
The natural history of chronic pain in the community: a better prognosis
than in the clinic? J Rheumatol 1996, 23(9):1617–1620.
31. Papageorgiou AC, Silman AJ, Macfarlane GJ: Chronic widespread pain in
the population: a seven year follow up study. Ann Rheum Dis 2002,
61(12):1071–1074.
32. Bergman S, Herrstrom P, Jacobsson LT, Petersson IF: Chronic widespread
pain: a three year followup of pain distribution and risk factors.
J Rheumatol 2002, 29(4):818–825.
33. Forseth KO, Forre O, Gran JT: A 5.5 year prospective study of self-reported
musculoskeletal pain and of fibromyalgia in a female population:
significance and natural history. Clin Rheumatol 1999, 18(2):114–121.
34. Campbell LC, Clauw DJ, Keefe FJ: Persistent pain and depression:
a biopsychosocial perspective. Biol Psychiatry 2003, 54(3):399–409.
35. Holmen J, Midthjell K, Krüger O, Langhammer A, Holmen TL, Bratberg GH,
Vatten L, Lund-Larsen PG: The Nord-Trøndelag Health Study 1995–97
(HUNT 2): Objectives, contents, methods and participation. Norsk
Epidemiologi 2003, 13(1):19–33.
36. Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T,
Bratberg G, Heggland J, Holmen J: Cohort profile: the HUNT study,
Norway. Int J Epidemiol 2012, 42(4):968–977.
37. Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-Sorensen F, Andersson
G, Jorgensen K: Standardised Nordic questionnaires for the analysis of
musculoskeletal symptoms. Appl Ergon 1987, 18(3):233–237.
38. Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ: The
epidemiology of chronic syndromes that are frequently unexplained:do they have common associated factors? Int J Epidemiol 2006,
35(2):468–476.
39. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P,
Russell AS, Russell IJ, Winfield JB, Yunus MB: The American college of
rheumatology preliminary diagnostic criteria for fibromyalgia and
measurement of symptom severity. Arthritis Care Res (Hoboken) 2010,
62(5):600–610.
40. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the hospital
anxiety and depression scale. An updated literature review. J Psychosom
Res 2002, 52(2):69–77.
41. Mykletun A, Stordal E, Dahl AA: Hospital Anxiety and Depression (HAD)
scale: factor structure, item analyses and internal consistency in a large
population. Br J Psychiatry 2001, 179:540–544.
42. Stordal E, Bjelland I, Dahl AA, Mykletun A: Anxiety and depression in
individuals with somatic health problems. The Nord-Trondelag
Health Study (HUNT). Scand J Prim Health Care 2003, 21(3):136–141.
43. Riskind JH, Beck AT, Berchick RJ, Brown G, Steer RA: Reliability of DSM-III
diagnoses for major depression and generalized anxiety disorder using
the structured clinical interview for DSM-III. Arch Gen Psychiatry 1987,
44(9):817–820.
44. World Health Organization: Obesity: preventing and managing the global
epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser
2000, 894:i–xii. 1–253.
45. Wong WS, Fielding R: Prevalence and characteristics of chronic
pain in the general population of Hong Kong. J Pain 2011,
12(2):236–245.
46. Langhammer A, Krokstad S, Romundstad P, Heggland J, Holmen J: The
HUNT study: participation is associated with survival and depends on
socioeconomic status, diseases and symptoms. BMC Med Res Methodol
2012, 12:143.
47. Gran JT: The epidemiology of chronic generalized musculoskeletal pain.
Best Pract Res Clin Rheumatol 2003, 17(4):547–561.
48. Leveille SG, Zhang Y, McMullen W, Kelly-Hayes M, Felson DT: Sex differences
in musculoskeletal pain in older adults. Pain 2005, 116(3):332–338.
49. Clauw DJ, Crofford LJ: Chronic widespread pain and fibromyalgia: what
we know, and what we need to know. Best Pract Res Clin Rheumatol 2003,
17(4):685–701.
50. DeSantana JM, Sluka KA: Central mechanisms in the maintenance of
chronic widespread noninflammatory muscle pain. Curr Pain Headache
Rep 2008, 12(5):338–343.
51. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B: Epidemiology
of multimorbidity and implications for health care, research, and
medical education: a cross-sectional study. Lancet 2012, 380(9836):37–43.
52. Taylor AW, Price K, Gill TK, Adams R, Pilkington R, Carrangis N, Shi Z, Wilson
D: Multimorbidity - not just an older person's issue. Results from an
Australian biomedical study. BMC public health 2010, 10:718.
53. Gagliese L: Pain and aging: the emergence of a new subfield of pain
research. J Pain 2009, 10(4):343–353.
54. Bair MJ, Robinson RL, Katon W, Kroenke K: Depression and pain
comorbidity: a literature review. Arch Intern Med 2003, 163(20):2433–2445.
55. Macfarlane GJ, McBeth J, Silman AJ: Widespread body pain and mortality:
prospective population based study. BMJ 2001, 323(7314):662–665.
56. Macfarlane GJ, Morris S, Hunt IM, Benjamin S, McBeth J, Papageorgiou AC,
Silman AJ: Chronic widespread pain in the community: the influence of
psychological symptoms and mental disorder on healthcare seeking
behavior. J Rheumatol 1999, 26(2):413–419.
57. McBeth J, Macfarlane GJ, Hunt IM, Silman AJ: Risk factors for persistent
chronic widespread pain: a community-based study. Rheumatology
(Oxford) 2001, 40(1):95–101.
58. Benjamin S, Morris S, McBeth J, Macfarlane GJ, Silman AJ: The association
between chronic widespread pain and mental disorder: a population-
based study. Arthritis Rheum 2000, 43(3):561–567.
59. Dersh J, Polatin PB, Gatchel RJ: Chronic pain and psychopathology:
research findings and theoretical considerations. Psychosom Med 2002,
64(5):773–786.
60. McBeth J, Macfarlane GJ, Silman AJ: Does chronic pain predict future
psychological distress? Pain 2002, 96(3):239–245.
61. Janke EA, Collins A, Kozak AT: Overview of the relationship between pain
and obesity: What do we know? Where do we go next? J Rehabil Res Dev
2007, 44(2):245–262.
Mundal et al. BMC Musculoskeletal Disorders 2014, 15:213 Page 12 of 12
http://www.biomedcentral.com/1471-2474/15/21362. Tukker A, Visscher TL, Picavet HS: Overweight and health problems of the
lower extremities: osteoarthritis, pain and disability. Public Health Nutr
2009, 12(3):359–368.
63. Wright LJ, Schur E, Noonan C, Ahumada S, Buchwald D, Afari N: Chronic
pain, overweight, and obesity: findings from a community-based twin
registry. J Pain 2010, 11(7):628–635.
doi:10.1186/1471-2474-15-213
Cite this article as: Mundal et al.: Prevalence and long-term predictors
of persistent chronic widespread pain in the general population in an
11-year prospective study: the HUNT study. BMC Musculoskeletal
Disorders 2014 15:213.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
